World
Jackson ImmunoResearch announces new range of detection reagents for R&D and diagnostic markets
Jackson ImmunoResearch, manufacturer of secondary antibodies and immunoreagents for the life science market, announces a new range of detection reagents th...
April 13, 2022 | News
Microba Life Sciences and Ginkgo Bioworks Announce Partnership to Discover Novel Live Biotherapeutics
Microba Life Sciences (ASX:MAP), a precision microbiome science company, and Ginkgo Bioworks (NYSE: DNA), the leading horizontal ...
April 05, 2022 | News
Waters Introduces Xevo TQ Absolute – The Most Sensitive and Compact Benchtop Tandem Quadrupole Mass Spectrometer
Waters Corporation (NYSE:WAT) today introduced the new Xevo™ TQ Absolute system, the most sensitive and compact benchtop tandem mass spec in its...
March 31, 2022 | News
Boehringer Ingelheim Selects Veeva Development Cloud Worldwide to Bring Innovative Therapies to Patients Faster
Transformation focuses on reducing complexity and developing an innovative, digital culture to better understand and address unmet medical needs Boehringe...
March 30, 2022 | News
Free Guide to Colorectal Cancer Screening from NCCN Now Available in More Than a Dozen Languages
The National Comprehensive Cancer Network® (NCCN®) today announced new translations of the recently-published NCCN Guidelines for Pa...
March 28, 2022 | News
Innovent and Lilly Expand Strategic Partnership in Oncology
i) an agreement for Innovent to obtain the sole commercialization rights to import, market, promote, distribute and detail Cyramza® (ramucirumab) ...
March 28, 2022 | News
Akston Biosciences and Biolexis Collaborate to Launch a Room Temperature Stable 2nd Generation COVID-19 Vaccine in 130+ Countries
Biolexis will launch AKS-452 as “AmbiVax-CTM” for global markets where the cold chain elimination would contribute to improving immunization ...
March 21, 2022 | News
Novavax Announces Launch of Global Vaccine Education Programs
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases,...
March 11, 2022 | News
Lonza Leads Market with Large and HLA-Typed CD34+ Cell Lots for Efficient Humanized Mouse Model Development
CD34+ cell lots in a range of sizes also now available with high-resolution HLA information, eliminating the need for cumbersome and costly HLA screening...
March 08, 2022 | News
Biocon Biologics to Acquire Viatris' Biosimilar Assets for Up to US$3.335 Billion in Cash and Equity
Biocon Biologics Ltd., a subsidiary of Biocon Ltd. (BSE: 532523) (NSE: BIOCON), has entered into a definitive agreement with its partner Viatris Inc. (NASD...
March 03, 2022 | News
Moderna and Thermo Fisher Scientific Announce Long-Term Strategic Collaboration
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Thermo Fisher Scientific Inc. (NYS...
February 25, 2022 | News
Thermo Fisher Scientific Launches New Portfolio of Chromatography and Mass Spectrometry Consumables
Thermo Scientific SureSTART consumables portfolio is designed for higher performance requirements, while meeting customer budgets A new collection of caps...
February 21, 2022 | News
Thermo Fisher Scientific expands Applied Biosystems portfolio
The Applied Biosystems SeqStudio Flex Series Genetic Analyzer delivers high-quality Sanger sequencing and fragment analysis data while providing design and...
February 10, 2022 | News
mRNA COVID-19 Vaccines are Safe for People with Cancer According to New Study in JNCCN
New research in the February 2022 issue of JNCCN—Journal of the National Comprehensive Cancer Network confirms that mRNA vaccine ...
February 08, 2022 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
